文献速递胸部CT

基于人工智能的CT评估支气管扩张:COPDGene研究

Artificial Intelligence-based CT Assessment of Bronchiectasis: The COPDGene Study.
PubMed 文献 · Radiology · 2022-12-13

本研究为COPDGene前瞻性多中心观察性研究的二次分析,纳入4192名曾经吸烟者,使用人工智能工具量化CT上气道与动脉直径比(AAR)大于1的气道百分比。结果显示该百分比与随访期间总急性加重次数相关,风险比(RR)为1.08(95%CI 1.02,1.15;符合支气管扩张临床和影像标准(即临床表现为AAR大于1的气道百分比≥3%)者RR为1.37(95%CI 1.31,1.43;

要点

  • AI可自动量化CT上AAR大于1的气道百分比。
  • AAR大于1的气道百分比与肺急性加重次数独立相关。
  • 满足AAR大于1气道百分比≥3%者加重风险更高。

诊断标准与关键数值

  • AAR大于1的气道百分比用于评估气道扩张。
  • 支气管扩张的临床和影像标准定义为:临床表现为AAR大于1的气道百分比≥3%。

临床应用与阅片要点

  • AI可自动量化CT上AAR大于1的气道百分比,辅助评估支气管扩张的 extent。
  • 满足AAR大于1气道百分比≥3%且临床有表现者,急性加重风险更高,可在报告中提示。

局限性

  • 本研究为二次分析。
  • 研究人群为曾经吸烟者,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background CT is the standard method used to assess bronchiectasis. A higher airway-to-artery diameter ratio (AAR) is typically used to identify enlarged bronchi and bronchiectasis; however, current imaging methods are limited in assessing the extent of this metric in CT scans. Purpose To determine the extent of AARs using an artificial intelligence-based chest CT and assess the association of AARs with exacerbations over time. Materials and Methods In a secondary analysis of ever-smokers from the prospective, observational, multicenter COPDGene study, AARs were quantified using an artificial intelligence tool. The percentage of airways with AAR greater than 1 (a measure of airway dilatation) in each participant on chest CT scans was determined. Pulmonary exacerbations were prospectively determined through biannual follow-up (from July 2009 to September 2021). Multivariable zero-inflated regression models were used to assess the association between the percentage of airways with AAR greater than 1 and the total number of pulmonary exacerbations over follow-up. Covariates included demographics, lung function, and conventional CT parameters. Results Among 4192 participants (median age, 59 years; IQR, 52-67 years; 1878 men [45%]), 1834 had chronic obstructive pulmonary disease (COPD). During a 10-year follow-up and in adjusted models, the percentage of airways with AARs greater than 1 (quartile 4 vs 1) was associated with a higher total number of exacerbations (risk ratio [RR], 1.08; 95% CI: 1.02, 1.15; P = .01). In participants meeting clinical and imaging criteria of bronchiectasis (ie, clinical manifestations with ≥3% of AARs >1) versus those who did not, the RR was 1.37 (95% CI: 1.31, 1.43; P < .001). Among participants with COPD, the corresponding RRs were 1.10 (95% CI: 1.02, 1.18; P = .02) and 1.32 (95% CI: 1.26, 1.39; P < .001), respectively. Conclusion In ever-smokers with chronic obstructive pulmonary disease, artificial intelligence-based CT measures of bronchiectasis were associated with more exacerbations over time. Clinical trial registration no. NCT00608764 © RSNA, 2022 Supplemental material is available for this article. See also the editorial by Schiebler and Seo in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Díaz, Nardelli, Wang, et al. Artificial Intelligence-based CT Assessment of Bronchiectasis: The COPDGene Study. Radiology. 2022. PMID: 36511808. doi:10.1148/radiol.221109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。